Registry for Esophageal and Gastroesophageal Junction Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The purpose of this registry study is to create a database-a collection of information-for better understanding standard treatments for esophageal and Gastroesophageal Junction Cancer/GEJ cancer. Researchers will use the information from this database to learn more about the effectiveness of different treatment options.
Eligibility criteria
Qualifiers
Retroperitoneal lymph nodes (e.g., para-aortal, intra-aorto-caval, parapancreatic, or mesenterial lymph node)
Liver
Lung
Extra-abdominal lymph nodes (e.g., supraclavicular or cervical lymph nodes)
Disqualifiers
Peritoneum, including positive peritoneal lavage (on the basis of baseline diagnostic laparoscopy to rule out gross disease and positive peritoneal lavage cytology; laparoscopy may be omitted for patients in whom all sites of disease are above the diaphragm)
Malignant pleural effusion
Brain metastases or leptomeningeal disease
Other sites not specifically noted must be reviewed and approved by the PIs
Trial design
Treatments tested in this trial
- EORTC QLQ-C30 questionnaire
- QLQ-OGS25 questionnaire
Treatment groups
50 Participants
are divided into 1 treatment groupLocations
1Memorial Sloan Kettering Cancer Center (All Protocol Activities)10065, New YorkNew York, United States
Sponsors and collaborators
Memorial Sloan Kettering Cancer Center
Lead sponsor
Source ClinicalTrials.gov